Get the app
US › Healthcare

IRIDEX Corporation (IRIX)

US · Healthcare · Medical Devices

$0.81-1.20%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$12.6M
Revenue YoY
-7.4%
Net profit
$-1.3M
EPS
$-0.07
EPS estimate
$-0.01
Net margin
-10.1%

EPS came in at -0.07 against a street estimate of -0.01 — a miss of 600.0%.

Key statistics

Market cap
$14.5M
Forward P/E
769.2
P/B
331.20
Book value
$-0.14
EPS (TTM)
$-0.20
52-week high
$1.65
52-week low
$0.61
50-day MA
$0.74
200-day MA
$1.07
Beta
0.67

Analyst view

Analysts rate IRIDEX Corporation a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.75.

Shareholding

Insiders
36.69%
Institutions
19.46%

Largest institutional holders

FundStake
PARAGON Assoc & PARAGON Assoc II JV5.69%
Vanguard Capital Management, LLC2.93%
Renaissance Technologies Corp2.41%
Weber Capital Management LLC1.03%
Geode Capital Management, LLC0.79%
Citadel Advisors Llc0.56%
Perkins Capital Management Inc0.40%
Vanguard Fiduciary Trust Co0.34%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for IRIDEX Corporation — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.